To include your compound in the COVID-19 Resource Center, submit it here.

Ajinomoto Pharmaceuticals Co. Ltd., Eisai, Takeda sales and marketing update

Ajinomoto and Eisai announced the launch of once-monthly 75

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE